Bio-Techne Named Researchers' Choice by CiteAb
Bio-Techne is honored to receive the CiteAb Researchers’ Choice Award for 2018! The annual awards aim to celebrate the very best suppliers and individuals in the research reagent sector worldwide.
The award of Researchers’ Choice reflects what researchers’ really think about the companies they get a wide range of reagents from for their work. It was noted that Bio-Techne stood out to the judges in this category.
Bio-Techne and its family of world-class brands including R&D Systems, Novus Biologicals, Tocris Bioscience, Boston Biochem, Trevigen, ProteinSimple, BiosPacific, Cliniqa and Advanced Cell Diagnostics, received numerous nominations from researchers around the world, all outlining the excellent quality of products and standards of service they have experienced.
Here are some of the nominations that Bio-Techne received from the CiteAb award for Researchers’ Choice:
“I have been consistently impressed with the high quality of Bio-Techne’s reagents for the ubiquitin field.”
“I have utmost confidence in Bio-Techne’s products and have been able to discuss my personal research needs with the company.”
“The products are of great quality and the sales team is extremely friendly and knowledgeable. It is always a good sign when you see the same staff year after year and it’s great to be able to build personal relationships - it really encourages trust and collaboration.”
In addition to the Researchers’ Choice Award Bio-Techne received, we were also recognized in the Innovative Product of the Year category for our Janelia Fluor® Dyes from Tocris Biosciences.
Everyone at Bio-Techne is honored to receive recognition from our customers and peers from these awards. We promise to continue to provide our customers with the best possible user experience, innovative products, and supportive staff to help researchers make scientific breakthroughs now and well into the future.
Read the full press release regarding Researchers’ Choice Award and the thoughts of our Senior Vice President, Dave Eansor.